Why the study?
What is the optimal antithrombotic protocol (vitamin K antagonist vs antiplatelet therapy) in the early postoperative period after bioprosthetic aortic valve replacement?
Population
Patients receiving bioprosthetic aortic valve replacement
Design
Review
Key result
A precise antithrombotic protocol for the early postoperative period after bioprosthetic aortic valve replacement remains unresolved, with important differences between international guidelines.
Authors
Loading...
Individualize early antithrombotic therapy after bioprosthetic AVR by patient risk; leaves open the optimal protocol pending dedicated RCTs.
What is the optimal antithrombotic protocol (vitamin K antagonist vs antiplatelet therapy) in the early postoperative period after bioprosthetic aortic valve replacement?
This review highlights the lack of consensus and conflicting guidelines regarding the optimal early antithrombotic management after bioprosthetic aortic valve replacement.
Colli et al. (2007) conducted a review in Bioprosthetic aortic valve replacement. Vitamin K antagonist or antiplatelet therapy was evaluated. A precise antithrombotic protocol for the early postoperative period after bioprosthetic aortic valve replacement remains unresolved, with important differences between international guidelines.